Opinion
Author and therapist Charles Wininger asks what would happen if millions of people across the political spectrum arose tomorrow and said ENOUGH of vitriol and demonization, suspicion and media-induced bitterness and hatred and instead received information from their higher selves rather than from divisive devices and screaming screens?
Ismail Lourido Ali, JD, Co-Executive Director of The Multidisciplinary Association for Psychedelic Studies (MAPS), offers thoughts on what to watch out for in the psychedelic sector in 2026.
Essayist Jim Tate warns psychedelic journalists who become high-profile influencers that drifting from rigorous, evidence-based reporting can impact the safety of people who seek experiences with substances that can affect their mental health.
Journalist Don Lattin writes that a new study examining the impact of psychedelic use on religious experiences supports his view that much of psychedelic research and journalism takes place in an echo chamber of self-reinforcing beliefs.
Consumer products marketed as containing psilocybin or other psychedelics are often mislabeled, and may instead contain potentially harmful synthetic compounds that evade fragmented regulatory frameworks.
The U.S. military attacks on alleged drug boats do nothing to address the dangers posed by illegal drugs and are instead being used as a pretext for possible land invasions and the further erosion of civil liberties that could target drug users in the U.S.
Author Erik Davis argues that some Christians resist demonizing psychedelics and are reaching across the ideological divide to acknowledge that these substances can spark sacred encounters and ease suffering.
From DMT vapes to MDMA gummies, psilocybin mushroom chocolate bars, and LSD microdots, an expanding range of psychedelic Consumer Packaged Goods (CPG) products is becoming increasingly available in the U.S. and Europe.
Thanks to organizing from local advocacy organizations, Minnesota has quietly become a hotbed of reform launching a psychedelic task force and deprioritized arrests related to entheogenic plants and fungi.
Bia Labate of the Chacruna Institute believes that it’s time to rethink psychedelic risk and end the prohibitionist mindset.
